| Literature DB >> 17145071 |
Fabiano R Castro1, Alessandro S Farias, Patricia L F Proença, Cristiane de La Hoz, Francesco Langone, Elaine C Oliveira, Marcos H Toyama, Sergio Marangoni, Leonilda M B Santos.
Abstract
Biomedical research in which venom components are being investigated for their potential as novel therapeutic agents has emerged as an interesting option. Crotapotin, which is purified from the venom of the rattlesnake Crotalus durissus terrificus, has been described as an anti-inflammatory agent that acts on the innate arm of the immune response. Here we have demonstrated that intraperitoneal administration of crotapotin significantly reduces the severity of experimental autoimmune neuritis (EAN), an experimental model for Guillain-Barré syndrome. The reduction of the severity of the disease is associated with a reduction in the mononuclear cells infiltrating the sciatic nerve and a significant decrease in the lymphocyte proliferative response to neuritogenic peptide.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17145071 DOI： 10.1016/j.toxicon.2006.09.028
Source DB: PubMed Journal: Toxicon ISSN： 0041-0101 Impact factor: 3.033